BSECompany Update9h ago · 11 Aug 2026, 07:02 pm
Regulation 32-Nil variation statement
Ganesh Benzoplast Ltd · 500153
✦ AI SummaryDebt Restruc.
Ganesh Benzoplast Ltd has filed a statement of deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026. The company has reported a deviation in the use of funds for one of the preferential issues, but not for the other. The deviation is due to a change in the objects of the issue, which was approved by the shareholders on September 25, 2025.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ganesh Benzoplast Ltd - 500153 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI (LODR) Regulations, 2015
Attachments (1)
📄pdf
Download →
f19217c8-acd6-47dd-ae2b-8c09c70a4ea4.pdf
View document text
GANESH BENZOPLAST LIMITED
CIN: L24200MH1986PLC039836
Regd. Office: Dina Building, 1st Floor, 53, Maharshi Karve Road, Marine Lines, Mumbai - 400 002
Tel: 022- 6140 6000/22001928
Email: compliance@gblinfra.com Website: www.ganeshbenzoplast.com
August 11, 2026
The General Manager, The Manager,
Department of Corporate Services – Listing Department
Corporate Relations Department, National Stock Exchange of India Limited
BSE Limited, Exchange Plaza, 5th Floor,
Pheeroze Jeejeebhoy Towers, Plot No. C/1, G-Block, Bandra Kurla
Dalal Street, Fort, Complex,
Mumbai – 400 001. Bandra (E), Mumbai – 400051
Scrip ID: 500153 Scrip ID: GANESHBE
Dear Sir,
Sub: Statement of Deviation or Variation in Utilization of Funds under Regulation 32 of
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing
Regulations”) for the Quarter ended June 30, 2026
Pursuant to Regulation 32 and other applicable provisions of the SEBI (LODR) Regulations,
2015 read with SEBI circulars issued in this regard, please find enclosed herewith the Statement
of Deviation or Variation in utilization of funds raised through preferential issue by the
Company for the First quarter ended June 30, 2026. We hereby confirm that there has been no
Deviation or Variation in the use of proceeds of funds raised through preferential issue.
We request you to kindly take the above information on your record.
Thanking you,
Yours Faithfully,
For Ganesh Benzoplast Ltd.
Rishi Pilani
Chairman & Managing Director
(DIN 00901627)
Encl: As above
Corp Office: 501/ 502, 'C' Wing, Lotus Corporate Park, Off. Western Express Highway, Laxmi
Nagar, Goregaon (East), Mumbai - 400063.
B. Statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. –
Statement of Deviation / Variation In utilisation of funds raised
Name of listed entity GANESH BENZOPLAST LIMITED
Mode of Fund Raising Preferential Issue of Equity Shares
Date of Raising Funds 01-03-2024
Amount Raised Rupees 324.00 million
Report filed for Quarter ended June 30,2026
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable Not Applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms Not Applicable
of a contract or objects, which was approved by the
shareholders
If Yes, Date of shareholder Approval Not Applicable
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review NIL
Comments of the auditors, if any NIL
Objects for which funds have been raised and where
there has been a deviation, in the following table
Original Object Modified Original Modified Funds Amount of Remarks
Object, if any Allocation allocation, if Utilised as on deviation/ if any
any June 30, 2026 Variation for
quarter
according
to applicable
object
For (i) capitalexpenditure and working capital Not Applicable Rs. 324.00 Nil Nil Nil -
requirements of the Company, its subsiadries, joint million
ventures or associates (ii) funding the Business
expansion directly by the Company or through its
subsidiaries or joint ventures or associates for the growth
of existing businesses or to enter into new business in
line with the strategy of the Company and (iii) general
corporate purposes of the Company.
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.
Statement of Deviation / Variation In utilisation of funds raised
Name of listed entity GANESH BENZOPLAST LIMITED
Mode of Fund Raising Preferential Issue of Equity Shares
Date of Raising Funds 12-01-2024
Amount Raised Rupees 303.50 million
Report filed for Quarter ended June 30, 2026
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable Not Applicable
Is there a Deviation / Variation in use of funds raised Yes
If yes, whether the same is pursuant to change in terms of Yes
a contract or objects, which was approved by the
shareholders
If Yes, Date of shareholder Approval 25-09-2025
Explanation for the Deviation / Variation Change in Objects of the Issue
Comments of the Audit Committee after review NIL
Comments of the auditors, if any NIL
Objects for which funds have been raised and where there
has been a deviation, in the following table
Original Object Modified Object, if any* Original Modified Funds Amount of Remarks
Allocation allocation, if Utilised as on deviation/ if any
any June 30, 2026 Variation for
quarter
according
to applicable
object
For LPG Business expansion directly by the Company or i) establishment of Infrastructure for Rs. 303.50 Rs. 303.50 Rs. 279.26 Nil -
through its subsidiaries or joint ventures or associates handling Liquids and gases including LPG million million million
and other general corporate business requirements. and ammonia tanks; (ii) business
expansion, directly or through
subsidiaries, joint ventures, or
associates, for growth of existing
businesses and entry into new
opportunities in line with the Company’s
strategy; (iii) capital expenditure and
working capital requirements of the
Company, its subsidiaries, joint ventures,
or associates; and (iv) general
corporate purposes.
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.
*Note: Objects of the Issue were modified with the approval of members in Annual General Meeting held on September 25, 2025.However there is no deviation in ulilization of funds.